MedTrace Logo

Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia

NCT06791668 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-01-24

No results posted yet for this study

Summary

The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. The main question this study aims to answer is:

What are the different regimens of magnesium sulphate that are used to prevent seizures in pregnant women with severe pre-eclampsia?

Participants already have taken the magnesium sulphate as part of their regular medical care for severe pre-eclampsia. Researchers will look into the records of the participants in the past 5 years to collect the data.

Conditions

  • Preeclampsia (PE)

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-03
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06791668 on ClinicalTrials.gov